Specific Antibodies, Levofloxacin, and Modulation of Capsule-Associated Virulence in Streptococcus pneumoniae

Documenti analoghi

• Effects of Amoxicillin Subinhibitory Concentrations on the Cross-Protection Developed by Pneumococcal Antibodies in Mouse Sepsis Caused by an Amoxicillin-Resistant Serotype 6B Streptococcus pneumoniae Strain
  di: Tarragó, D., et al.
  Pubblicazione: (2004)
• In Vitro Activity of Ceftaroline against Streptococcus pneumoniae Isolates Exhibiting Resistance to Penicillin, Amoxicillin, and Cefotaxime
  di: Fenoll, Asunción, et al.
  Pubblicazione: (2008)
• Evolution of Clonal and Susceptibility Profiles of Serotype 19A Streptococcus pneumoniae among Invasive Isolates from Children in Spain, 1990 to 2008
  di: Tarragó, David, et al.
  Pubblicazione: (2011)
• Combined Effect of Specific Antibodies (as Serotherapy or Preimmunization) and Amoxicillin Doses in Treatment of Streptococcus pneumoniae Sepsis in a Mouse Model
  di: Yuste, J., et al.
  Pubblicazione: (2002)
• Temporal Trends of Invasive Streptococcus pneumoniae Serotypes and Antimicrobial Resistance Patterns in Spain from 1979 to 2007
  di: Fenoll, A., et al.
  Pubblicazione: (2009)